10 Posts not to miss from the 2025 Texas Lung Cancer Conference – Dr. Estela Rodriguez
The 2025 Texas Lung Cancer Conference (#TexasLung25) took place from April 10–12 at the iconic ACL Live at the Moody Theater in Austin, Texas. This IASLC-endorsed, CE-accredited event brought together leading experts in thoracic oncology to discuss the latest advancements in lung cancer care, including immunotherapy, targeted therapies, and innovative treatment approaches .
Dr. Estela Rodriguez, Associate Director of Community Outreach in Thoracic Oncology at the University of Miami’s Sylvester Comprehensive Cancer Center, actively participated in the conference, sharing insights and highlights on X. Here are some of her notable posts:
- Celebrating Women Leaders in Thoracic Surgery
“Women Leaders in thoracic surgery discussing how important it is to take time to do a check-in with your personal & professional goals. Great advice from Mara Antonoff, Jessica Donington, Brittany Bank, Leah Backhus, Brittany Simmons, Jessica Geiger and Shanda Blackmon.”
- Highlighting Women in Thoracic Oncology
” Women in Thoracic Oncology breakfast with great leaders discussing their career paths to leadership positions.”
- Acknowledging Mentees’ Achievements
“TexasLung25 Like a proud parent I only see my own mentee in the picture. Congratulations to our Sylvester Cancer team for their excellent poster presentation!”
- Discussing Lung Cancer Fusions
“Excellent panel of experts on Lung cancer fusions: ALK, ROS1, RET, NTRK/NRG1.
Consensus on lorlatinib as 1L for ALK+ NSCLC.
Great insights from Ross Camidge, Alex Drilon, Ben Solomon, Jessica Lin and Christine Lovly.”
- Reflecting on the Conference’s Impact
“When in Texas go Big!
TexasLung25 is like the Grammys of Thoracic oncology conferences with the best hosts Stephen Liu and Tina Cascone. Thank you for organizing such an impactful event!”
- Sharing Keynote Highlights
“Mike Posner (Grammy nominated singer-songwriter – ‘I Took a Pill in Ibiza’ fame) Gives an empowering Keynote speech and performance. Inspiring to see art and medicine intersect!”
Link to the video attached. - Engaging in Discussions on EGFR Lung Cancer
“Rachel Sanborn – If we move our best therapies upfront, what are the 2nd line options for EGFR lung cancer beyond platinum-chemo? Important considerations for treatment sequencing.”
- Highlighting Patient Advocacy
“Jill Feldman – ‘Research moves forward because patient advocates refuse to stand still’ – amazing overview of the history of lung cancer advocacy and how it has shaped research priorities.”
For more updates from Texas Lung 25, follow OncoDaily.
By Md Foorquan Hashmi, MD, Sr. Editor, OncoDaily: India Bureau
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023